Nicox S.A. Actions Port. EO 1

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

22.37%

Market Cap

18.01 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.03 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.295 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 08:17:42 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.3210.295
PREV. DAY'S PRICE0.323 (07/21)
CHANGE DAY BEFORE
-0.03
-8.67 %
52 WEEK HIGH / LOW0.7 (08/08)0.25 (12/19)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.42-0.32-0.03-0.070.01
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
----37.00
PRICE - BOOK RATIO
1.035.674.36--
PRICE - SALES RATIO
3.192.461.43--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A143G8
ISIN
FR0013018124
SYMBOL
NXOA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Nicox
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
50.01 Mil.
MARKET CAPITALISATION
18.01 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.84 %
-5.88 %
-11.60 %
8.47 %
22.37 %
-25.58 %
-90.45 %
15.94 %
HIGH0.390.400.410.560.700.703.810.56
LOW0.290.290.270.270.250.110.110.26

Dividende

pro Aktie
Nicox does not deliver dividend information

Company profile

Nicox SA is an ophthalmology company. The firm engages in developing solutions to help maintain vision and improve ocular health. Its products include Zerviate and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Biot, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.